10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001576280-23-000060 |
| Period End Date | 20230331 |
| Filing Date | 20230509 |
| Fiscal Year | 2023 |
| Fiscal Period | Q1 |
| XBRL Instance | gh-20230331_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
73 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Preferred stock, par value (in usd per share) |
PreferredStockParOrStatedValuePerShare
|
- | USD | Point-in-time |
| Preferred stock, par value (in usd per share) |
PreferredStockParOrStatedValuePerShare
|
- | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$573.60M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$141.65M | USD | Point-in-time |
| Preferred stock issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$223.64M | USD | Point-in-time |
| Preferred stock issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Short-term marketable debt securities |
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
$869.58M | USD | Point-in-time |
| Preferred stock outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Short-term marketable debt securities |
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
$713.38M | USD | Point-in-time |
| Preferred stock outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$97.26M | USD | Point-in-time |
| Common stock, par value (in usd per share) |
CommonStockParOrStatedValuePerShare
|
- | USD | Point-in-time |
| Common stock, par value (in usd per share) |
CommonStockParOrStatedValuePerShare
|
- | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$87.20M | USD | Point-in-time |
| Inventory, net |
InventoryNet
|
$51.60M | USD | Point-in-time |
| Inventory, net |
InventoryNet
|
$46.47M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
350.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
350.00M | shares | Point-in-time |
| Prepaid expenses and other current assets, net |
PrepaidExpenseAndOtherAssetsCurrent
|
$31.51M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
102.71M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
102.62M | shares | Point-in-time |
| Prepaid expenses and other current assets, net |
PrepaidExpenseAndOtherAssetsCurrent
|
$33.76M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
102.62M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$1.19B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$1.10B | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
102.71M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$163.23M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$167.92M | USD | Point-in-time |
| Right-of-use assets, net |
OperatingLeaseRightOfUseAsset
|
$170.65M | USD | Point-in-time |
| Right-of-use assets, net |
OperatingLeaseRightOfUseAsset
|
$174.00M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$11.05M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$11.73M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$3.29M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$3.29M | USD | Point-in-time |
| Other assets, net |
OtherAssetsNoncurrent
|
$61.45M | USD | Point-in-time |
| Other assets, net |
OtherAssetsNoncurrent
|
$58.95M | USD | Point-in-time |
| Total Assets |
Assets
|
$1.61B | USD | Point-in-time |
| Total Assets |
Assets
|
$1.51B | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$175.82M | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$190.53M | USD | Point-in-time |
| Deferred revenue |
ContractWithCustomerLiabilityCurrent
|
$17.40M | USD | Point-in-time |
| Deferred revenue |
ContractWithCustomerLiabilityCurrent
|
$13.62M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$193.22M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$204.16M | USD | Point-in-time |
| Convertible senior notes, net |
ConvertibleDebtNoncurrent
|
$1.14B | USD | Point-in-time |
| Convertible senior notes, net |
ConvertibleDebtNoncurrent
|
$1.14B | USD | Point-in-time |
| Long-term operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$210.01M | USD | Point-in-time |
| Long-term operating lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$204.86M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$9.14M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$9.18M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$1.55B | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$1.56B | USD | Point-in-time |
| Commitments and contingencies (Note 9) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 9) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2023 and December 31, 2022 |
PreferredStockValueOutstanding
|
- | USD | Point-in-time |
| Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2023 and December 31, 2022 |
PreferredStockValueOutstanding
|
- | USD | Point-in-time |
| Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of March 31, 2023, and December 31, 2022; 102,708,305 and 102,619,383 shares issued and outstanding as of March 31, 2023, and December 31, 2022, respectively |
CommonStockValueOutstanding
|
$1.00K | USD | Point-in-time |
| Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of March 31, 2023, and December 31, 2022; 102,708,305 and 102,619,383 shares issued and outstanding as of March 31, 2023, and December 31, 2022, respectively |
CommonStockValueOutstanding
|
$1.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$1.74B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$1.76B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-19.52M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-12.15M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-1.80B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-1.66B | USD | Point-in-time |
| Total Stockholders (Deficit) Equity |
StockholdersEquity
|
$60.18M | USD | Point-in-time |
| Total Stockholders (Deficit) Equity |
StockholdersEquity
|
$-44.55M | USD | Point-in-time |
| Total Stockholders (Deficit) Equity |
StockholdersEquity
|
$533.04M | USD | Point-in-time |
| Total Stockholders (Deficit) Equity |
StockholdersEquity
|
$645.00M | USD | Point-in-time |
| Total Liabilities and Stockholders (Deficit) Equity |
LiabilitiesAndStockholdersEquity
|
$1.51B | USD | Point-in-time |
| Total Liabilities and Stockholders (Deficit) Equity |
LiabilitiesAndStockholdersEquity
|
$1.61B | USD | Point-in-time |
Income Statement
40 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Precision oncology testing |
RevenueFromPrecisionOncologyTesting
|
$84.14M | USD | 1 Quarter |
| Precision oncology testing |
RevenueFromPrecisionOncologyTesting
|
$113.39M | USD | 1 Quarter |
| Development services and other |
RevenueFromDevelopmentServices
|
$15.32M | USD | 1 Quarter |
| Development services and other |
RevenueFromDevelopmentServices
|
$11.96M | USD | 1 Quarter |
| Total revenue |
Revenues
|
$96.10M | USD | 1 Quarter |
| Total revenue |
Revenues
|
$128.71M | USD | 1 Quarter |
| Cost of precision oncology testing |
CostsOfPrecisionOncologyTesting
|
$30.68M | USD | 1 Quarter |
| Cost of precision oncology testing |
CostsOfPrecisionOncologyTesting
|
$45.11M | USD | 1 Quarter |
| Cost of development services and other |
CostOfDevelopmentServices
|
$1.30M | USD | 1 Quarter |
| Cost of development services and other |
CostOfDevelopmentServices
|
$7.97M | USD | 1 Quarter |
| Research and development expense |
ResearchAndDevelopmentExpense
|
$93.13M | USD | 1 Quarter |
| Research and development expense |
ResearchAndDevelopmentExpense
|
$81.76M | USD | 1 Quarter |
| Sales and marketing expense |
SellingAndMarketingExpense
|
$76.12M | USD | 1 Quarter |
| Sales and marketing expense |
SellingAndMarketingExpense
|
$64.43M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$41.27M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$40.45M | USD | 1 Quarter |
| Total costs and operating expenses |
CostsAndExpenses
|
$219.44M | USD | 1 Quarter |
| Total costs and operating expenses |
CostsAndExpenses
|
$262.77M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-134.06M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-123.34M | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$778.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$3.06M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$644.00K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$644.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$-1.65M | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$-48.00K | USD | 1 Quarter |
| Loss before provision for (benefit from) income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-123.25M | USD | 1 Quarter |
| Loss before provision for (benefit from) income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-133.29M | USD | 1 Quarter |
| Provision for (benefit from) income taxes |
IncomeTaxExpenseBenefit
|
$240.00K | USD | 1 Quarter |
| Provision for (benefit from) income taxes |
IncomeTaxExpenseBenefit
|
$-24.00K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-123.23M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-133.53M | USD | 1 Quarter |
| Net loss per share, basic (in usd per share) |
EarningsPerShareBasic
|
$-1.30 | USD | 1 Quarter |
| Net loss per share, basic (in usd per share) |
EarningsPerShareBasic
|
$-1.21 | USD | 1 Quarter |
| Net loss per share, diluted (in usd per share) |
EarningsPerShareDiluted
|
$-1.30 | USD | 1 Quarter |
| Net loss per share, diluted (in usd per share) |
EarningsPerShareDiluted
|
$-1.21 | USD | 1 Quarter |
| Weighted-average shares used in computing net loss per share , basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
101.85M | shares | 1 Quarter |
| Weighted-average shares used in computing net loss per share , basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
102.66M | shares | 1 Quarter |
| Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
101.85M | shares | 1 Quarter |
| Weighted-average shares used in computing net loss per share attributable to Guardant Health, Inc. common stockholders, diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
102.66M | shares | 1 Quarter |
Cash Flow Statement
79 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-123.23M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-133.53M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$10.35M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$7.20M | USD | 1 Quarter |
| Operating lease costs |
NonCashOperatingLeaseCosts
|
$7.34M | USD | 1 Quarter |
| Operating lease costs |
NonCashOperatingLeaseCosts
|
$6.95M | USD | 1 Quarter |
| Contingent consideration |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-300.00K | USD | 1 Quarter |
| Contingent consideration |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$2.39M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$22.27M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$24.80M | USD | 1 Quarter |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$644.00K | USD | 1 Quarter |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$642.00K | USD | 1 Quarter |
| Amortization of (discount) premium on marketable debt securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$-2.45M | USD | 1 Quarter |
| Amortization of (discount) premium on marketable debt securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$1.01M | USD | 1 Quarter |
| Unrealized gains on marketable equity securities |
EquitySecuritiesFvNiUnrealizedGainLoss
|
$3.88M | USD | 1 Quarter |
| Unrealized gains on marketable equity securities |
EquitySecuritiesFvNiUnrealizedGainLoss
|
- | USD | 1 Quarter |
| Impairment of non-marketable equity securities |
OtherAssetImpairmentCharges
|
$5.49M | USD | 1 Quarter |
| Impairment of non-marketable equity securities |
OtherAssetImpairmentCharges
|
- | USD | 1 Quarter |
| Other |
OtherNoncashIncomeExpense
|
- | USD | 1 Quarter |
| Other |
OtherNoncashIncomeExpense
|
$-21.00K | USD | 1 Quarter |
| Accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-12.35M | USD | 1 Quarter |
| Accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-13.30M | USD | 1 Quarter |
| Inventory, net |
IncreaseDecreaseInInventories
|
$5.94M | USD | 1 Quarter |
| Inventory, net |
IncreaseDecreaseInInventories
|
$-5.12M | USD | 1 Quarter |
| Prepaid expenses and other current assets, net |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$3.35M | USD | 1 Quarter |
| Prepaid expenses and other current assets, net |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-21.88M | USD | 1 Quarter |
| Other assets, net |
IncreaseDecreaseInOtherOperatingAssets
|
$-1.76M | USD | 1 Quarter |
| Other assets, net |
IncreaseDecreaseInOtherOperatingAssets
|
$-3.85M | USD | 1 Quarter |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
|
$13.89M | USD | 1 Quarter |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
|
$20.93M | USD | 1 Quarter |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-7.42M | USD | 1 Quarter |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-3.11M | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$-757.00K | USD | 1 Quarter |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$-4.14M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-74.44M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-28.62M | USD | 1 Quarter |
| Purchase of marketable debt securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$163.74M | USD | 1 Quarter |
| Purchase of marketable debt securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$63.25M | USD | 1 Quarter |
| Maturity of marketable debt securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$310.00M | USD | 1 Quarter |
| Maturity of marketable debt securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$228.00M | USD | 1 Quarter |
| Purchase of non-marketable equity securities and other related investments |
PaymentsToAcquireEquitySecuritiesFvNi
|
- | USD | 1 Quarter |
| Purchase of non-marketable equity securities and other related investments |
PaymentsToAcquireEquitySecuritiesFvNi
|
$12.75M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$7.52M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$22.70M | USD | 1 Quarter |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$157.22M | USD | 1 Quarter |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$110.81M | USD | 1 Quarter |
| Payments made on finance lease obligations |
FinanceLeasePrincipalPayments
|
$18.00K | USD | 1 Quarter |
| Payments made on finance lease obligations |
FinanceLeasePrincipalPayments
|
$18.00K | USD | 1 Quarter |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$157.00K | USD | 1 Quarter |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$963.00K | USD | 1 Quarter |
| Taxes paid related to net share settlement of restricted stock units |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$957.00K | USD | 1 Quarter |
| Taxes paid related to net share settlement of restricted stock units |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$993.00K | USD | 1 Quarter |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-854.00K | USD | 1 Quarter |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-12.00K | USD | 1 Quarter |
| Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-792.00K | USD | 1 Quarter |
| Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-163.00K | USD | 1 Quarter |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$81.77M | USD | 1 Quarter |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$81.39M | USD | 1 Quarter |
| Cash, cash equivalents and restricted cashBeginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$492.29M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashBeginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$573.67M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashBeginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$223.71M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashBeginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$141.95M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashEnd of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$492.29M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashEnd of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$573.67M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashEnd of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$223.71M | USD | Point-in-time |
| Cash, cash equivalents and restricted cashEnd of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$141.95M | USD | Point-in-time |
| Operating lease liabilities arising from obtaining right-of-use assets |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$3.94M | USD | 1 Quarter |
| Operating lease liabilities arising from obtaining right-of-use assets |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$1.96M | USD | 1 Quarter |
| Purchase of property and equipment included in accounts payable and accrued liabilities |
CapitalExpendituresIncurredButNotYetPaid
|
$8.02M | USD | 1 Quarter |
| Purchase of property and equipment included in accounts payable and accrued liabilities |
CapitalExpendituresIncurredButNotYetPaid
|
$19.75M | USD | 1 Quarter |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$573.60M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$141.65M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$223.64M | USD | Point-in-time |
| Restricted cash included in other assets, net |
RestrictedCashNoncurrent
|
$74.00K | USD | Point-in-time |
| Restricted cash included in other assets, net |
RestrictedCashNoncurrent
|
$69.00K | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$492.29M | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$573.67M | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$223.71M | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$141.95M | USD | Point-in-time |
Stockholders Equity
20 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance |
StockholdersEquity
|
$60.18M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$-44.55M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$533.04M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$645.00M | USD | Point-in-time |
| Issuance of common stock upon exercise of stock options (in shares) |
StockIssuedDuringPeriodSharesStockOptionsExercised
|
21,049.00 | shares | 1 Quarter |
| Issuance of common stock upon exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$157.00K | USD | 1 Quarter |
| Issuance of common stock upon exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$963.00K | USD | 1 Quarter |
| Vesting of common stock exercised early |
StockIssuedDuringPeriodValueExerciseOfWarrants
|
$8.00K | USD | 1 Quarter |
| Taxes paid related to net share settlement of restricted stock units |
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
$957.00K | USD | 1 Quarter |
| Taxes paid related to net share settlement of restricted stock units |
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
$993.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$22.27M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$24.80M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-13.55M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$7.37M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-123.23M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-133.53M | USD | 1 Quarter |
| Ending balance |
StockholdersEquity
|
$60.18M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$-44.55M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$533.04M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$645.00M | USD | Point-in-time |
Comprehensive Income
10 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-123.23M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-133.53M | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-12.76M | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$7.54M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-163.00K | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-792.00K | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-13.55M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$7.37M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-126.16M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-136.78M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.